Vanda Pharmaceuticals | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Acadia Pharmaceuticals USD 765.24M 32.44M 2025-03
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Arrowhead Research USD 684.22M 631.64M 2025-03
AstraZeneca USD 41.04B 168M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Halozyme Therapeutics USD 482.27M 118.45M 2025-03
Insmed USD 99.16M 186.22M 2025-03
J&J USD 78.11B 6.62B 2025-03
Ligand Pharmaceuticals USD 795.53M 34.9M 2025-03
Merck USD 48.34B 2.02B 2025-03
Moderna USD 10.07B 835M 2025-03
Novartis USD 44.05B 729M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
PTC Therapeutics USD -185760000 912.31M 2025-03
Sanofi 74.07B 3.78B 2025-03
Takeda JPY 6.94T 483.19B 2025-03
Teva Pharmaceutical Industries USD 6.26B 542M 2025-03
Ultragenyx Pharmaceutical USD 144.25M 111.05M 2025-03
Veracyte USD 1.19B 18.97M 2025-03



Vanda Pharmaceuticals Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.